Reference | Type | LOE | Follow-up | Inclusion period | Knees at final FU | Mean Age (y) | Sex (M/F) | Surgical details | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ACL | ACL + LA | All | ACL | ACL + LA | ACL | ACL + LA | ACL | ACL + LA | ACL | ACL + LA |  |  | ||||||
(Mo) | Start | End | Start | End | Â | Â | Â | Â | Â | Â | Â | Graft | ACL graft | AL type | AL graft | |||
Castoldi et al. [1] | RCT | I | 232.8 | 01/1998 | 09/1999 | 01/1998 | 09/1999 | 80 | 42 | 38 | NR | NR | NR | NR | BPTB | BPTB | LET | Grac |
Ibrahim et al. [26] | RCT | II | 27 | 01/2014 | 06/2014 | 01/2014 | 06/2014 | 103 | 50 | 53 | 26 | 26 | 50/0 | 53/0 | HT | HT | ALLR | Grac |
Hamido et al. [18] | RCT | I | 60 | 04/2014 | 03/2015 | 04/2014 | 03/2015 | 102 | 52 | 50 | 26 | 24 | 52/0 | 50/0 | HT | HT | ALLR | Grac |
Sonnery-Cottet et al. [55] | Cohort | II | 38.4 | 01/2012 | 05/2014 | 01/2012 | 05/2014 | 502 | 176 | 221 | 23.5 | 21.8 | 116/60 | 152/69 | HT | HT | ALLR | Grac |
 |  |  |  | 01/2012 | 05/2014 | - | - | - | 105 | - | 22.1 | - | 96/9 | - | BPTB | - | - | - |
Goncharov et al. [15] | Cohort | II | 24 | 2014 | 2015 | 2014 | 2015 | 48 | 30 | 18 | NR | NR | NR | NR | BPTB | BPTB | ALLR | Grac/SemiT |
Helito et al. [21] | Cohort | III | 26 | 01/2011 | 06/2012 | 01/2014 | 06/2015 | 101 | 68 | 33 | 33.9 | 33.1 | 59/9 | 30/03 | HT | HT | ALLR | Grac |
Helito et al. [22] | Cohort | III | 28.1 | 01/2011 | 01/2013 | 01/2015 | 08/2016 | 90 | 60 | 30 | 29.9 | 27 | 28/32 | 13/17 | HT | HT | ALLR | Grac |
Rowan et al. [50] | Cohort | III | 27 | NR | NR | NR | NR | 171 | 125 | 46 | 29 | 27 | 67/58 | 27/19 | HT | HT | LET | ITB |
Porter et al. [45] | RCT | II | 24 | 07/2014 | 01/2017 | 07/2014 | 01/2017 | 51 | 23 | 28 | 22.3 | 21.8 | NR | NR | HT | HT | MITBT | ITB |
Getgood et al. [14] | RCT | I | 24 | 01/2014 | 03/2017 | 01/2014 | 03/2017 | 589 | 298 | 291 | 18.8 | 19.1 | NR | NR | HT | HT | LET | ITB |
Vadalà et al. [58] | Cohort | II | 44.6 | 01/2005 | 12/2006 | 01/2005 | 12/2006 | 55 | 28 | 27 | 28 | 26 | NR | NR | HT | HT | CA | ITB |